Prelude Therapeutics Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Wilmington, DE
SEC filing record 1 source field available
Fiscal year end
31 December
Prelude Therapeutics Inc has filed 386 SEC EDGAR filings since 11 Jul 2016

SEC filing history

Showing 301-325 of 386 matching filings.

Per page
25
Current page
13
4

FORM 4 SUBMISSION

Filing date
21 Apr 2021
Reporting date
19 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Apr 2021
Reporting date
07 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Apr 2021
Reporting date
07 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Apr 2021
Reporting date
07 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Apr 2021
Reporting date
07 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39527

8-K

Filing date
17 Mar 2021
Reporting date
17 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-254349

S-8

Filing date
16 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39527

8-K

Filing date
16 Mar 2021
Reporting date
16 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39527

8-K

Filing date
08 Mar 2021
Reporting date
02 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91717

SC 13G

Filing date
11 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91717

SC 13G/A filing

Filing date
10 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91717

SC 13G filing

Filing date
08 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Jan 2021
Reporting date
27 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91717

SCHEDULE 13D/A

Filing date
29 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39527

8-K

Filing date
28 Jan 2021
Reporting date
22 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91717

AMENDMENT NO. 1

Filing date
14 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Jan 2021
Reporting date
11 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Jan 2021
Reporting date
11 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Jan 2021
Reporting date
11 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-251874

424B4

Filing date
07 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .